Sulfonylureas as second line treatment for type 2 diabetes

BMJ ◽

10.1136/bmj.k3041 ◽

2018 ◽

pp. k3041 ◽

Author(s):

Lucy D’Agostino McGowan ◽

Christianne L Roumie

Keyword(s):

Type 2 Diabetes ◽

Line Treatment ◽

Download Full-text

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/review5 ◽

2020 ◽

Author(s):

Tiansheng Wang

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/review1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Decision letter for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v3/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/review2 ◽

2020 ◽

Author(s):

Tiansheng Wang

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Comparative effectiveness of gliclazide modified release versus sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes

Diabetes Obesity and Metabolism ◽

10.1111/dom.14169 ◽

2020 ◽

Vol 22 (12) ◽

pp. 2417-2426

Author(s):

Francesco Zaccardi ◽

Emmanuelle Jacquot ◽

Viviana Cortese ◽

Freya Tyrer ◽

Samuel Seidu ◽

...

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study

Annals of Medicine ◽

10.3109/07853890.2016.1157263 ◽

2016 ◽

Vol 48 (4) ◽

pp. 224-234 ◽

Author(s):

Jil Mamza ◽

Rajnikant Mehta ◽

Richard Donnelly ◽

Iskandar Idris

Keyword(s):

Type 2 Diabetes ◽

Cohort Study ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Treatment Options ◽

Line Treatment ◽

Second Line ◽

Glycaemic Response

Download Full-text

Comparative Efficacy and Safety of Empagliflozin with Other Oral Antidiabetic Drugs for the Second Line Treatment of Type 2 Diabetes Mellitus

Value in Health ◽

10.1016/j.jval.2014.08.631 ◽

2014 ◽

Vol 17 (7) ◽

pp. A333

Author(s):

K. Thorlund ◽

G. Siliman ◽

S. Eapen ◽

S. Lund ◽

R. Palencia

Keyword(s):

Diabetes Mellitus ◽

Type 2 Diabetes ◽

Type 2 Diabetes Mellitus ◽

Line Treatment ◽

Second Line ◽

Efficacy And Safety ◽

Oral Antidiabetic Drugs ◽

Comparative Efficacy ◽

Oral Antidiabetic

Download Full-text

Decision letter for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Decision letter for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v1/decision1 ◽

2020 ◽

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text

Review for "Comparative effectiveness of gliclazide modified release vs sitagliptin as second‐line treatment after metformin monotherapy in patients with uncontrolled type 2 diabetes"

10.1111/dom.14169/v2/review3 ◽

2020 ◽

Author(s):

Alanna Weisman

Keyword(s):

Type 2 Diabetes ◽

Comparative Effectiveness ◽

Line Treatment ◽

Second Line ◽

Modified Release ◽

Metformin Monotherapy

Download Full-text